Application of click chemistry for signal amplification in IHC and ISH assays
US-12517132-B2 · Jan 6, 2026 · US
Water-soluble benzoazepine compound and its pharmaceutical composition
US9809609B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9809609-B2 |
| Application number | US-201213461642-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 1, 2012 |
| Priority date | Dec 27, 2005 |
| Publication date | Nov 7, 2017 |
| Grant date | Nov 7, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a benzoazepine compound represented by following general formula (1): or a salt thereof, wherein R represents a hydrogen atom, a hydroxy group optionally protected with a protecting group, etc., R 1 represents a hydrogen atom or hydroxy-protecting group, and X represents an oxygen atom or a sulfur atom. The benzoazepine compound of the present invention and salts thereof have high solubility in water, and can be suitably used for injections.
First claim
Opening claim text (preview).
The invention claimed is: 1. A benzoazepine compound represented by formula (1) or a salt thereof, wherein R represents a hydrogen atom, a hydroxy group optionally protected with a protecting group, a mercapto group optionally protected with a protecting group, or an amino group optionally protected with one or two protecting groups; R 1 represents a hydrogen atom or…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9809609B2 cover?
- The present invention provides a benzoazepine compound represented by following general formula (1): or a salt thereof, wherein R represents a hydrogen atom, a hydroxy group optionally protected with a protecting group, etc., R 1 represents a hydrogen atom or hydroxy-protecting group, and X represents an oxygen atom or a sulfur atom. The benzoazepine compound of th…
- Who is the assignee on this patent?
- Komatsu Makoto, Goto Fumitaka, Menjo Yasuhiro, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification C07F9/5535. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).